|
Slotkoers
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 27/10 | Irlab Therapeutics krijgt naar verwachting Amerikaans octrooi voor kandidaat-geneesmiddel tegen de ziekte van Parkinson | MT |
| 27/10 | Irlab ontvangt positief patentbesluit in de VS voor IRL1117 | FW |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1,04% | +10,23% | +23,37% | +25,74% | +31,20% | +57,27% | +142,98% | +448,95% | +1.840,77% | 1.263 mld. | |
| -1,48% | +0,92% | +4,96% | +5,63% | +29,86% | +44,28% | +78,87% | +62,29% | +133,97% | 658 mld. | |
| -1,90% | +1,10% | +10,30% | +18,28% | +26,87% | +36,77% | +102,36% | +148,77% | +410,47% | 521 mld. | |
| -1,54% | +0,18% | +14,90% | +11,57% | +21,02% | +53,06% | +66,79% | +8,10% | +77,08% | 391 mld. | |
| -0,36% | +5,77% | +3,07% | +16,40% | +41,30% | +80,30% | +44,61% | +67,07% | +152,77% | 369 mld. | |
| -1,69% | +3,17% | +13,05% | +5,64% | +20,00% | +32,18% | +55,35% | +71,16% | +89,37% | 307 mld. | |
| -0,72% | +7,83% | +16,76% | +20,52% | +0,51% | +12,10% | +33,76% | +47,02% | +206,26% | 290 mld. | |
| -0,15% | +4,40% | +15,17% | +22,52% | +41,82% | +56,66% | +74,12% | +116,65% | +234,67% | 252 mld. | |
| -0,57% | +6,89% | +17,20% | +29,34% | +38,20% | +38,98% | +108,83% | +157,41% | +133,94% | 212 mld. | |
| +1,54% | +3,74% | +8,62% | -10,62% | -16,93% | -14,30% | -61,92% | -24,31% | +127,15% | 175 mld. | |
| -0,05% | +2,03% | +9,33% | +21,43% | +22,07% | +23,26% | -0,34% | -33,12% | -0,77% | 174 mld. | |
| +0,83% | +9,05% | +11,81% | +19,89% | +24,48% | +32,47% | +49,87% | +211,10% | +623,51% | 142 mld. | |
| +0,29% | +1,73% | +2,49% | -4,27% | +16,19% | +36,19% | +22,58% | +6,90% | +23,94% | 128 mld. | |
| +1,03% | +0,99% | +11,13% | +21,22% | +22,23% | +22,23% | +124,01% | +357,98% | +638,18% | 116 mld. | |
| +1,12% | +8,11% | +13,87% | +8,23% | -2,53% | -7,26% | -7,53% | -10,02% | +12,22% | 107 mld. | |
| -1,64% | -4,73% | +2,53% | -4,45% | 0,00% | +3,84% | +30,69% | -6,71% | -9,14% | 99,63 mld. | |
| +4,85% | +20,32% | +32,18% | +27,99% | +25,90% | +51,31% | +18,68% | +52,13% | +182,77% | 93,11 mld. | |
| +1,82% | +14,20% | +19,51% | +311,83% | +670,04% | +811,62% | +218,81% | -34,87% | - | 88,52 mld. | |
| -0,86% | +4,46% | +9,57% | +5,30% | +22,35% | +34,23% | +4,57% | -28,54% | +62,73% | 73,45 mld. | |
| Gemiddelde | -0,04% | +5,36% | +12,62% | +29,06% | +54,45% | +73,96% | +58,27% | +85,16% | +274,44% | 287,26 mld. | |
| Gewogen gemiddelde per kap. | -0,72% | +6,10% | +13,74% | +20,80% | +35,45% | +54,78% | +79,50% | +159,70% | +576,80% |
- Beurs
- Aandelen
- Koers IRLAB A
- Koers
- Sector IRLAB Therapeutics AB
Kies jouw editie
Alle financiële informatie op nationaal niveau
